A novel near-patient host-protein score predicts COVID-19 deterioration at presentation to secondary care.

Rahul Atul Shah, Alexander J Mentzer, Tim James, Stuart Cox, Kevin Paddon, Jordan Bowen, James N Fullerton

Abstract readLetter

In one paragraph

Article in The Journal of infection, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rahul Atul ShahOxford University Clinical Academic Graduate School, University of Oxford, Oxford, UK. Electronic address: rahulshah2@doctors.org.uk.

Alexander J MentzerWellcome Centre for Human Genetics, University of Oxford, Oxford, UK; Acute General Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Tim JamesDepartment of Clinical Biochemistry, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Stuart CoxDepartment of Clinical Biochemistry, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Kevin PaddonDepartment of Clinical Biochemistry, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Jordan BowenAcute General Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

James N FullertonAcute General Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Oxford Centre for Clinical Therapeutics (OCCT), Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK. Electronic address: james.fullerton@ndorms.ox.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HumansRetrospective StudiesSARS-CoV-2Secondary Health Care

Identifiers

PMID36681156

DOI10.1016/j.jinf.2023.01.017

PMCPMC9847215

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.